BUD vs MDLZ
Anheuser-Busch InBev SA/NV and Mondelez International, Inc., side by side — 10 fiscal years reported in USD, drawn from SEC filings.
Most recent reported year
| Metric | BUD | MDLZ |
|---|---|---|
| Revenue | $59.3B | $38.5B |
| Net income | $6.8B | $2.5B |
| Gross margin | 55.9% | 28.4% |
| Net margin | 14.3% | 6.4% |
| Return on equity | 8.3% | 9.3% |
| Diluted EPS | $3.39 | $1.89 |
| Dividend / share | · | $1.94 |
| Payout ratio | 66.4% | 101.5% |
| Free cash flow | $11.2B | $3.2B |
| Equity | $87.3B | $25.8B |
| Net debt / equity | 0.70× | 0.69× |
| Current ratio | 0.72× | 0.59× |
| Revenue CAGR 5y | 4.8% | 7.7% |
| Profit CAGR 5y | 37.2% | −7.2% |
BUD bills 1.5× the revenue of MDLZ, and keeps more of each dollar of revenue as profit (14.3% against 6.4%).
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner. "·" marks a figure not available in our data.
10 years side by side
| Fiscal year | BUD | MDLZ |
|---|---|---|
| FY2025 | $59.3B | $38.5B |
| FY2024 | $59.8B | $36.4B |
| FY2023 | $59.4B | $36.0B |
| FY2022 | $57.8B | $31.5B |
| FY2021 | $54.3B | $28.7B |
| FY2020 | $46.9B | $26.6B |
| FY2019 | $52.3B | $25.9B |
| FY2018 | $53.0B | $25.9B |
| FY2017 | $54.9B | $25.9B |
| FY2016 | $45.5B | $25.9B |
Bottom line
| Fiscal year | BUD | MDLZ |
|---|---|---|
| FY2025 | $6.8B | $2.5B |
| FY2024 | $5.9B | $4.6B |
| FY2023 | $5.3B | $5.0B |
| FY2022 | $6.0B | $2.7B |
| FY2021 | $4.7B | $4.3B |
| FY2020 | $1.4B | $3.6B |
| FY2019 | $9.2B | $3.9B |
| FY2018 | $4.4B | $3.3B |
| FY2017 | $8.0B | $2.8B |
| FY2016 | $1.2B | $1.6B |
11 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2025 | +$20,783,000,000 | BUD |
| FY2024 | +$23,327,000,000 | BUD |
| FY2023 | +$23,364,000,000 | BUD |
| FY2022 | +$26,290,000,000 | BUD |
| FY2021 | +$25,584,000,000 | BUD |
| FY2020 | +$20,300,000,000 | BUD |
| FY2019 | +$26,461,000,000 | BUD |
| FY2018 | +$27,103,000,000 | BUD |
| FY2017 | +$28,963,000,000 | BUD |
| FY2016 | +$19,594,000,000 | BUD |
| FY2015 | +$13,428,000,000 | BUD |
BUD has reported the higher revenue in every one of these 11 fiscal years. The gap has widened since the earliest year compared.
11 of 19 comparable fiscal years — a year missing data on either side is not counted.
11 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2025 | +7.9 pp | BUD |
| FY2024 | −0.3 pp | MDLZ |
| FY2023 | −2.2 pp | MDLZ |
| FY2022 | +4.5 pp | BUD |
| FY2021 | −3.8 pp | MDLZ |
| FY2020 | −8.7 pp | MDLZ |
| FY2019 | +4.7 pp | BUD |
| FY2018 | −2.1 pp | MDLZ |
| FY2017 | +5.7 pp | BUD |
| FY2016 | −0.3 pp | MDLZ |
| FY2015 | −1.7 pp | MDLZ |
The higher net margin has changed hands between BUD and MDLZ over this period.
11 of 19 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
BUD's net margin has been more volatile than MDLZ's over the 11 comparable fiscal years — 5.1 percentage points of standard deviation against 4.8.
11 of 19 comparable fiscal years — a year missing data on either side is not counted.
Year by year
The lead in net margin changed hands between BUD and MDLZ over these 11 fiscal years — BUD led in 4 and MDLZ in 7.
11 of 19 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
MDLZ's return on equity has been more volatile than BUD's over the 10 comparable fiscal years — 3.5 percentage points of standard deviation against 3.3.
10 of 19 comparable fiscal years — a year missing data on either side is not counted.
Year by year
The lead in return on equity changed hands between BUD and MDLZ over these 10 fiscal years — BUD led in 1 and MDLZ in 9.
10 of 19 comparable fiscal years — a year missing data on either side is not counted.